10X Genomics (TXG) PT Raised to $47 at Piper Sandler

August 10, 2026 7:16 AM

Piper Sandler analyst David Westenberg raised the price target on 10X Genomics (NASDAQ: TXG) to $47.00 (from $42.00) while maintaining a Neutral rating.

No results found